Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation

Visceral leishmaniasis (VL) is a lethal disease if left untreated. Current treatments produce variable rates of treatment failure and toxicity without sterile cure, rendering treatment efficacy monitoring essential. To avoid repeated invasive tissue aspirates as well as empirical treatment, there is...

Full description

Bibliographic Details
Main Authors: Yetemwork Aleka, Ana Victoria Ibarra-Meneses, Meseret Workineh, Fitsumbrhan Tajebe, Amare Kiflie, Mekibib Kassa Tessema, Roma Melkamu, Azeb Tadesse, Javier Moreno, Johan van Griensven, Eugenia Carrillo, Wim Adriaensen
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/8385672